Get all your news in one place
100’s of premium titles. One news app. Zero ads. Just $10 per month.
Benzinga

Recap: Arcadia Biosciences Q1 Earnings

Arcadia Biosciences (NASDAQ:RKDA) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Arcadia Biosciences beat estimated earnings by 41.18%, reporting an EPS of $-0.2 versus an estimate of $-0.34.

Revenue was up $2.39 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.12 which was followed by a 25.93% drop in the share price the next day.

Here's a look at Arcadia Biosciences's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.30 -0.29 -0.27 -0.30
EPS Actual -0.42 -0.15 -0.24 0.11
Revenue Estimate 3.33M 2.51M 1.71M 850.00K
Revenue Actual 2.17M 2.38M 1.41M 828.00K

To track all earnings releases for Arcadia Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.